| Literature DB >> 28342104 |
Scott Ryall1,2, Uri Tabori1,3, Cynthia Hawkins4,5,6.
Abstract
Gliomas are the most common central nervous system neoplasms affecting children and can be both high- and low-grade. Paediatric low-grade glioma may be either World Health Organization grade I or grade II. Despite being classified as grade II diffuse astrocytoma, these neoplasms arising in children are distinct clinically and molecularly from their adult counterparts. They do not tend to progress to higher grade lesions and only rarely harbour an IDH mutation. Here, we review the clinical, histologic and molecular features of paediatric grade II diffuse glioma, highlighting their diagnostic criteria, prevalence across brain locations, their most common molecular features and how to test for them, and lastly the current status of therapeutic options available for their treatment.Entities:
Keywords: Clinical trials; Histology; Incidence; Low-grade diffuse glioma; Molecular events; Paediatric
Mesh：
Substances：
Year: 2017 PMID： 28342104 DOI： 10.1007/s10014-017-0282-z
Source DB: PubMed Journal: Brain Tumor Pathol ISSN： 1433-7398 Impact factor: 3.298